Off-Label Use of Ceftazidime/Avibactam for the Treatment of Pan-Drug-Resistant Klebsiella pneumoniae in a Neonate: Case Report and Literature Review

Background: Klebsiella pneumoniae is among the most common Gram-negative bacteria isolated to neonatal intensive care units (NICU) and one of the leading causes of morbidity and mortality. The ceftazidime/avibactam (CAZ-AVI) combination is approved for infections caused by aerobic Gram-negative orga...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangarov, Iliya, Georgieva, Ralitsa, Petkova, Valentina, Nikolova, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451246/
https://www.ncbi.nlm.nih.gov/pubmed/37627722
http://dx.doi.org/10.3390/antibiotics12081302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451246/
https://www.ncbi.nlm.nih.gov/pubmed/37627722
http://dx.doi.org/10.3390/antibiotics12081302

Ejemplares similares